CNBSAmplify Seymour Cannabis ETF
Seeks to provide investors capital appreciation.
By Amplify ETFs · Launched 2019
Annual Cost
0.76%
#3,883 of 5,562 · expensive
Fund Size
$87M
#3,074 of 5,562 · mid-size
Return (1Y)Goal
+99.3%
Track Record
6 years
#1,936 of 5,562 · seasoned
Performance
Total-return NAV · USDGrowth of $10,000
$19,544+95.4%
Total-return NAV, USD. Net of fund fees, before tax.
Classification
How Beacon categorizes this fundWhat it actually holds
By weightConcentration
Top 10 holdings = 106.6% of fundconcentrated
TREASURY BILL
40.5%
TREASURY BILL
21.9%
TREASURY BILL
13.5%
Curaleaf Holdings Inc
11.4%
TREASURY BILL
10.5%
Innovative Industrial Properti
2.3%
Invesco Government & Agency Po
2.0%
TREASURY BILL
1.8%
WM Technology Inc
1.5%
TREASURY BILL
1.1%
Asset allocation
Stocks
90.0%
Other
12.4%
By sector
Healthcare
63.1%
Real Estate
13.8%
Technology
10.7%
Consumer Defensive
7.0%
Consumer Cyclical
3.4%
Financial Services
1.9%
Industrials
0.1%
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsVolatility (1Y)
105.8%High
Year-on-year price swings
Max drawdown
-95.7%Severe
Worst peak-to-trough loss
Sharpe (3Y)
0.29Below average
Sortino (3Y)
0.48Moderate downside risk
Where to buy
Listing
- Exchange
- NYSE Arca
Full fund details
- Objective
- Seeks to provide investors capital appreciation.
- Strategy
- Invests primarily in U.S. companies engaged in cannabis and hemp-related activities. Actively managed, focusing on firms deriving 50% or more of revenue from the cannabis ecosystem across various classifications.
- Inception date
- July 15, 2019
- Fund family
- Amplify ETFs
Similar ETFs
Closest matches by profileWhat's next?
You've reviewed CNBS. Save it to your watchlist to track it alongside the other funds you're weighing.
Data updated on 2026-06-19